Abstract
The vascular effects of 2-mercaptoethanol, cysteamine, L-cysteine, glutathione (GSH), cystamine and oxidized GSH (GSSG) on the isometric tension of isolated dog coronary arterial strips were examined, and these effects were compared with the triphasic response induced by dithiothreitol (DTT); a rapid and weak contraction (phase A), an intervening slow relaxation (phase B) and a slowly-developing strong contraction (phase C) which we previously reported. The responses of the arteries induced by 2-mercaptoethanol, cysteamine and L-cysteine consisted of phases A, B and C. The order of contractile potency (ED50 of phase C) was DTT≈L-cysteine>2-mercaptoethanol≈cysteamine, while the order of relaxant potency (ED50 of phase B) was DTT>cysteamine≈2-mercaptoethanol. GSSG and cystamine mainly produced relaxation, which corresponded to phase B. The phase C contraction was specific to the reduced forms of thiols, except for GSH, which produced only relaxation. The participation of endothelial cells was not essential for the contracting or relaxing effects of the thiol compounds. The phase C contraction was depressed by W-7, a calmodulin antagonist, while phase A was not. Therefore calmodulin-dependent protein kinases may participate in phase C, not in phase A.
Similar content being viewed by others
References
Gilbert, H. F., Meth. Enzym.107 (1984) 330.
Gilbert, H. F., Adv. Enzym. relat. Areas mol. Biol.63 (1990) 69.
Ziegler, D. M., A. Rev. Biochem.54 (1985) 305.
Myers, P. R., Minor, R. L. Jr., Guerra, R. Jr., Bates, J. N., and Harrison, D. G., Nature345 (1990) 161.
Ignarro, L. J., FASEB J.3 (1989) 31.
De Voorde, J. V., J. Cardiovasc. Pharmac.17, Suppl. 3 (1991) S304.
Fujioka, H., Horiike, K., Takahashi, M., Ishida, T., Kinoshita, M., and Nozaki, M., Eur. J. Pharmac.166 (1989) 13.
Hidaka, H., and Tanaka, T., Meth. Enzym.102 (1983) 185.
Weiss, B., Meth. Enzym.102 (1983) 171.
Furchgott, R. F., A. Rev. Pharmac. Toxicol.24 (1984) 175.
Cleland, W. W., Biochemistry3 (1964) 480.
Crane, D., Häussinger, D., Graf, P., and Sies, H., Hoppe-Seyler's Z. physiol. Chem.364 (1983) 977.
Ishii, T., Bannai, S., and Sugita, Y., J. biol. Chem.256 (1981) 12387.
Franchi-Gazzola, R., Gazzola, G. C., Dall'Asta, V., and Guidotti, G. G., J. biol. Chem.257 (1982) 9582.
Greenberg, S., Kadowitz, P. J., Long, J. P., and Wilson, W. R., Circ. Res.39 (1976) 66.
Asano, M., and Hidaka, H., Jap. J. Pharmac.33 (1983) 145.
Asano, M., and Hidaka, H., Jap. J. Pharmac.33 (1983) 227.
Steinsland, O. S., Furchgott, R. F., and Kirpekar, S. M., Circ. Res.32 (1973) 49.
Bolton, T. B., Physiol. Rev.59 (1979) 606.
Nakaki, T., Roth, B. L., Chuang, D.-M., and Costa, E., J. Pharmac. exp. Ther.234 (1985) 442.
Rasmussen, H., Takuwa, Y., and Park, S., FASEB J.1 (1987) 177.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fujioka, H., Horiike, K., Takahashi, M. et al. Triphasic vascular effects of thiol compounds and their oxidized forms on dog coronary arteries. Experientia 49, 47–50 (1993). https://doi.org/10.1007/BF01928788
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01928788